The DRIVE-AB consortium is busy preparing for the United Nations (UN) General Assembly high-level meeting on antimicrobial resistance, which will take place in New York on 26 September. This is only the third health issue to ever be discussed at this level at the UN General Assembly, following non-communicable diseases in 2011 and the first, HIV/AIDS, in 2001. The primary objective of the meeting is to summon and maintain strong national, regional and international political commitment in addressing antimicrobial resistance comprehensively and multi-sectorally, and to increase and improve awareness of antimicrobial resistance.
DRIVE-AB participants, other partner organizations such as ReAct and civil society representatives are contributing heavily to this meeting and we look forward to engaging with world leaders to take meaningful steps forward to addressing the threat of antimicrobial resistance.
DRIVE-AB will be disseminating our third policy brief, “Paying for greater antibiotic innovation”, to the participants of this meeting.